All Access

Biotech Deals

Biotech Deals Alert

Alert

McKesson and private equity firm Clayton, Dubilier & Rice plan to acquire Option Care Health in a deal valued at about $5.8 billion.

Follow the money: The deal values Option Care at $32.05 per share.

CD&R will hold a majority interest of about 51% under the agreement, and McKesson will invest about $1.4 billion for a minority interest of approximately 49%.

Between the lines: The transaction establishes a framework for McKesson to potentially acquire CD&R's stake, subject to certain conditions and regulatory approval.

How it works: Option Care is an independent provider of home and alternate site infusion services and specialty pharmacy services.  

Zoom in: Option Care will continue to be led by its own management team, per a statement.

Centerview and Kirkland & Ellis LLP advised Option Care. BofA Securities, Barclays, Goldman Sachs, Jefferies and Wells Fargo advised McKesson and CD&R along with providing committed financing to the consortium.

What's next: The transaction is expected to close in the first half of 2027.

McKesson and CD&R to acquire Option Care Health for around $5.8B

The $5.8 billion transaction establishes a framework for McKesson to potentially acquire CD&R's stake.

McKesson and private equity firm Clayton, Dubilier &amp; Rice plan to acquire Option Care Health in a deal valued at about $5.8 billion.Follow the money: The deal values Option Care at $32.05 per share.

topics

politics-policy

epstein-files

donald-trump

2026-midterm-elections

immigration

behind-the-curtain

race-and-equity

technology

privacy-tech-regulation

automation-and-ai

tiktok-news

big-tech

social-media

cybersecurity

economy

social-security

inflation

tariffs

federal-reserve

transportation

business

c-suite

retail-news

media

elon-musk

dealmaking

health

rfk-jr

drug-prices

axios-explains-abortion

public-health

world

israel

axios-explains-ukraine

iran

russia

china

energy-climate

nuclear-energy

climate-energy-policy

climate-change

extreme-weather

alternative-energy

electric-vehicles

science

emerging-tech

biomedicine

newsletters

charlotte

salt-lake-city

denver

fort-lauderdale

cincinnati

scottsdale

boulder

kansas-city

austin

chicago

dallas

detroit

atlanta

indianapolis

nashville

nw-arkansas

columbus

hollywood

washington-dc

north-of-cincy

mesa

richmond

san-francisco

boston

des-moines

houston

phoenix

miami

philadelphia

seattle

new-orleans

colorado-springs

huntsville

raleigh

san-antonio

twin-cities

pittsburgh

san-diego

tampa-bay

portland

cleveland

arapahoe

douglas

axios-local

axios-pro

axios-live

the-axios-show

McKesson and CD&R to acquire Option Care Health for around $5.8B

What to read next